Metformin Pharmacogenetics and SLC2A2: Genome-Wide Association Study and 2-stage replication in GoDARTS and UKPDS

Metformin Pharmacogenetics and SLC2A2: Genome-Wide Association Study and 2-stage replication in GoDARTS and UKPDS

Bibliographic Details
Main Authors:	Zhou, K, Bennett, A, Coleman, R, Groves, R, Holman, R, Mccarthy, M, Palmer, C, Pearson, E
Format:	Journal article
Published:	2013

Similar Items

Reduced-function SLC22A1 polymorphisms encoding organic cation transporter 1 and glycemic response to metformin: a GoDARTS study.
by: Zhou, K, et al.
Published: (2009)

Variation in TCF7L2 influences therapeutic response to sulfonylureas: a GoDARTs study.
by: Pearson, E, et al.
Published: (2007)

Metformin as first choice in oral diabetes treatment: the UKPDS experience.
by: Holman, R
Published: (2007)

Retinal vascular measures from diabetes retinal screening photographs and risk of incident dementia in type 2 diabetes: A GoDARTS study
by: Alexander S. F. Doney, et al.
Published: (2022-08-01)

Incident nephropathy in type 2 diabetes: a UKPDS Risk Equation
by: Coleman, R, et al.
Published: (2005)

UKPDS - 6-YEAR TRIAL OF SULFONYLUREA, INSULIN AND METFORMIN THERAPY IN TYPE-2 DIABETIC-PATIENTS WITH DIET FAILURE
by: Cull, C, et al.
Published: (1995)

UKPDS 28: A randomized trial of efficacy of early addition of metformin in sulfonylurea-treated type 2 diabetes
by: Wright, A, et al.
Published: (1998)

Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group.
by: Turner, R, et al.
Published: (1999)

Estimating risk of clinically evident neuropathy in Type 2 diabetes: a UKPDS risk equation
by: Coleman, R, et al.
Published: (2006)

Estimating cardiovascular disease risk for individuals with Type 2 diabetes: the new UKPDS Risk Engine
by: Coleman, R, et al.
Published: (2007)

Hypoglycaemia in patients with Type 2 diabetes in the UKPDS
by: Cull, C, et al.
Published: (2001)

Ethnicity and long-term vascular outcomes in Type 2 diabetes: a prospective observational study (UKPDS 83).
by: Davis, T, et al.
Published: (2014)

Ethnicity and long-term vascular outcomes in Type 2 diabetes: A prospective observational study (UKPDS 83)
by: Davis, T, et al.
Published: (2014)

Relationship between the severity of retinopathy and progression to photocoagulation in patients with Type 2 diabetes mellitus in the UKPDS (UKPDS 52).
by: Kohner, E, et al.
Published: (2001)

Forecasting coronary case fatality in type 2 diabetes: a UKPDS Risk Engine equation
by: Stevens, R, et al.
Published: (2002)

Changing aspirin use in patients with Type 2 diabetes in the UKPDS.
by: Cull, C, et al.
Published: (2004)

Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus - Progressive requirement for multiple therapies (UKPDS 49)
by: Turner, R, et al.
Published: (1999)

Variation in the glucose transporter gene SLC2A2 is associated with glycaemic response to metformin
by: Kaixin, Z, et al.
Published: (2016)

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)
by: Turner, R, et al.
Published: (1998)

Framingham equations underestimate cardiovascular risk compared with the UKPDS risk engine in people with Type 2 diabetes
by: Price, H, et al.
Published: (2007)

Estimating risk factor progression equations for the UKPDS Outcomes Model 2 (UKPDS 90)
by: Leal, J, et al.
Published: (2021)

Hypoglycemia in Type 2 diabetic patients randomized to and maintained on monotherapy with diet, sulfonylurea, metformin, or insulin for 6 years from diagnosis: UKPDS73.
by: Wright, A, et al.
Published: (2006)

Prognostic significance of silent myocardial infarction in newly diagnosed type 2 diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS) 79.
by: Davis, T, et al.
Published: (2013)

Plasma homocysteine, type 2 diabetes and risk of coronary heart disease in the UKPDS
by: Holman, R, et al.
Published: (2001)

Metformin Pharmacogenetics: Effects of SLC22A1, SLC22A2, and SLC22A3 Polymorphisms on Glycemic Control and HbA1c Levels
by: Laith N. AL-Eitan, et al.
Published: (2019-03-01)

Risk factors for myocardial infarction case fatality and stroke case fatality in type 2 diabetes: UKPDS 66.
by: Stevens, R, et al.
Published: (2004)

Risk factors for neuropathy in UKPDS
by: Stratton, I, et al.
Published: (2004)

Paraoxonase 2 (PON2) polymorphisms and development of renal dysfunction in type 2 diabetes: UKPDS 76.
by: Calle, R, et al.
Published: (2006)

UKPDS: Plasma leptin, obesity and plasma insulin in type 2 diabetic subjects
by: Widjaja, A, et al.
Published: (1996)

UKPDS58--modeling glucose exposure as a risk factor for photocoagulation in type 2 diabetes.
by: Stevens, R, et al.
Published: (2002)

Inaugural Conference: UKPDS Legacy and Precision Therapy for Type 2 Diabetes Mellitus
by: Rury Holman
Published: (2022-09-01)

Loss-of-function CYP2C9 variants improve therapeutic response to sulfonylureas in type 2 diabetes: a Go-DARTS study.
by: Zhou, K, et al.
Published: (2010)

Evaluating SCORE and Framingham fatal coronary heart disease risk equations using UKPDS data
by: Coleman, R, et al.
Published: (2004)

UKPDS 20: plasma leptin, obesity, and plasma insulin in type 2 diabetic subjects.
by: Widjaja, A, et al.
Published: (1997)

The impact of diabetes-related complications on healthcare costs: new results from the UKPDS (UKPDS 84).
by: Alva, M, et al.
Published: (2014)

Estimating cardiovascular risk and all-cause mortality in individuals with type 2 diabetes using the UKPDS Outcomes Model
by: Coleman, RL, et al.
Published: (2019)

A model to estimate the lifetime health outcomes of patients with type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS) Outcomes Model (UKPDS no. 68).
by: Clarke, P, et al.
Published: (2004)

Cost-effectiveness analysis of intensive blood-glucose control with metformin in overweight patients with type II diabetes (UKPDS No. 51).
by: Clarke, P, et al.
Published: (2001)

Ethnic differences in diabetic nephropathy - The UKPDS
by: Stevens, R, et al.
Published: (1999)

UKPDS: what was the question? UK Prospective Diabetes Study.
by: Turner, R, et al.
Published: (1999)